XNK Therapeutics to present two posters at the NK2023 conference in Oslo in September
XNK Therapeutics AB today announced that two posters, regarding bladder cancer and Acute Myeloid Leukemia (AML) respectively, will be presented at the 20[th] Meeting of the Society for Natural Immunity (NK2023) in Oslo, Norway, in September.XNK Therapeutics will participate at NK2023 in Oslo in September and present the latest research relating to the company’s leading natural killer (NK) cells therapies. Two abstracts have been accepted for presentation at the meeting. The data have been generated in collaboration with XNK’s external partners, Anders Ullén and Fernanda Costa Svedman at